Piedmont Healthcare

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Piedmont Healthcare sits in the top decile of US sponsors by registered trial count (#1,049 of 15,742 sponsors by registered trial count).

13 total trials none currently recruiting 9 completed top decile by trial count

Piedmont Healthcare: 13 sponsored US clinical trials, none currently recruiting.

Piedmont Healthcare sponsors 13 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 9 completed. 1 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Afib, with 1 trials.

Top-decile sponsor footprint

Piedmont Healthcare ranks in the top decile of sponsors by registered trial count (#1,049 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 27/100

9 of 12 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (75.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

13 total, page 1 of 1

ACTIVE NOT RECRUITING Early Phase 1

Efficacy of Aldosterone Antagonist Therapy for Prevention of New Atrial Fibrillation

NCT03929718
COMPLETED

Utilization of the Viracor® Assay for Valganciclovir Prophylaxis in CMV High Risk Kidney Transplant Recipients

NCT05238220
COMPLETED NA

ULTRAsound-assisted Catheter vs. STAndaRd Catheter Thrombolysis for Submassive Pulmonary Embolism

NCT03389971
COMPLETED

In-hospital and Long-term Outcomes for Percutaneous Chronic Total Coronary Occlusion Revascularization in a High-volume, Multi-operator Program

NCT01946724
COMPLETED

Individualized Comprehensive Atherosclerosis Risk-reduction Evaluation Program

NCT00969865
TERMINATED NA

MRI Evaluation of the Breast Areolar Margin and Paryenchyma

NCT01300585
COMPLETED NA

Atrio-Ventricular (AV) Delay Optimization Using Echocardiography Versus the SonR Signal

NCT01287234
TERMINATED NA

Transmyocardial Laser Revascularization and Cardiovascular Magnetic Resonance Imaging

NCT01287910
TERMINATED Phase 4

Same-Day Discharge After Coronary Percutaneous Transluminal Coronary Angioplasty (PTCA)

NCT01068119
COMPLETED

Detection of Subclinical Atherosclerosis in Asymptomatic Individuals

NCT00862056
COMPLETED NA

Validation of Stenosis Assessment by Coronary Artery Computed Tomography Against Invasive Measurements of Fractional Flow Reserve in Patients With Significant Coronary Artery Stenoses

NCT00817102
COMPLETED

Atherosclerotic Plaque Characterization

NCT00861653
COMPLETED

Cardiogenomics Registry

NCT00861575

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 4 1

Therapeutic Areas

Afib 1
Cardiovascular Disease 1
Atherosclerosis 1
Heart Failure 1

How the Piedmont Healthcare archive is shaped

13 indexed studies, none listed as recruiting (0% open); 9 completed (69%).

Phase mix: 1 late (III/IV) vs 1 early (I/II) (balanced across stages).

Top condition: Afib (1 trial), 3 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Piedmont Healthcare: archived-pipeline peers nationwide

Peers matched on 13 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Piedmont Healthcare sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%2%4%6%8%10% Total trials Recruiting share Piedmont HealthcareAdaptimmuneAgennixAkili Interactive LabsAlumis10xBio22nd Century Group23andMe3-C Institute for Social Development
Piedmont Healthcare sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Piedmont Healthcare sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 13 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Piedmont Healthcare page

13 registered trials is a research-attention snapshot, not an endorsement of Piedmont Healthcare or any single study.

  • None of Piedmont Healthcare's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Afib is the condition Piedmont Healthcare studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Afib trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Piedmont Healthcare pipeline card: 13 registered trials from official public datasets.Report a data error.